Study: Cannabis Inhaler Delivers Effective Relief To Neuropathy Patients

The administration of a single dose of whole-plant cannabis via a thermal-metered inhaler is effective and well tolerated among patients suffering from neuropathy (nerve pain), according to clinical trial data published online ahead of print in the Journal of Pain and Palliative Care Pharmacotherapy.

Israeli investigators assessed the efficacy of a novel, portable metered-dose cannabis inhaler in eight subjects diagnosed with chronic neuropathic pain. Researchers reported that the vaporizing device administered an efficient, consistent, and therapeutically effective dosage of cannabinoids to all participants.

They concluded, “This trial suggests the potential use of the Syqe Inhaler device as a smokeless delivery system of medicinal cannabis, producing a delta-9-THC pharmacokinetic profile with low inter-individual variation of (maximum drug/plasma concentrations), achieving pharmaceutical standards for inhaled drugs.”

A series of clinical trials conducted by investigators affiliated with the Center for Medicinal Cannabis Research  at the University of California, San Diego previously determined that the inhalation of whole-plant cannabis is efficacious in the treatment of various types of neuropathic pain.

Study: Cannabis Inhaler Delivers Effective Relief To Neuropathy Patients

Advertisements


Categories: Health

Tags: , , , ,

%d bloggers like this: